🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Dr. Ram Manohar Lohia Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our India register with Dr. Ram Manohar Lohia Hospital as lead sponsor. Synced 26 Sep 2026
4Current trials
1Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Dr. Ram Manohar Lohia Hospital is the lead sponsor of 4 current clinical trials in our India register. 1 is recruiting patients now. The most common phase is Phase 3. The most-studied condition is Non-invasive Ventilation.

ClinicalTrials.gov trials by status

  • Recruiting125%
  • Not yet open375%

Trials by phase

  • Phase 3375%
  • Observational125%
01

Clinical trials sponsored by Dr. Ram Manohar Lohia Hospital

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
An International Survey on the Use of NIV Outside the ICU
NCT07157215 · Non-invasive Ventilation, Intensive Care (ICU), Safety
Observational Recruiting 2025-09 India
Effect of Repetitive Bihemispheric Anodal Transcranial Direct Current Stimulation on Motor Function of Patients With Parkinson's Disease
NCT07395531 · ClinicalTrials.gov ↗ · PARKINSON DISEASE (Disorder), Parkinson Disease
Phase 3 Not yet open 2026-02 India
EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION ON NAMING IN APHASIC PATIENTS WITH ACUTE ISCHEMIC STROKE
NCT07496645 · ClinicalTrials.gov ↗ · Acute Ischemic Cerebrovascular Disease, Post Stroke Aphasia, Aphasia Following Cerebral Infarction
Phase 3 Not yet open 2026-03 India
EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) OF PRIMARY MOTOR CORTEX ON HEADACHE FREQUENCY IN PATIENTS WITH CHRONIC MIGRAINE
NCT07743814 · ClinicalTrials.gov ↗ · Chronic Migraine Headache, Chronic Migraine, Headache
Phase 3 Not yet open 2026-08 India

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Dr. Ram Manohar Lohia Hospital trials

11 conditions
Non-invasive Ventilation1Intensive Care (ICU)1Safety1PARKINSON DISEASE (Disorder)1Parkinson Disease1Acute Ischemic Cerebrovascular Disease1Post Stroke Aphasia1Aphasia Following Cerebral Infarction1Aphasia, Acquired1Chronic Migraine Headache1Chronic Migraine, Headache1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in India41

A trial with sites in more than one country appears in each of those registers.

04

Questions about Dr. Ram Manohar Lohia Hospital trials

How many clinical trials does Dr. Ram Manohar Lohia Hospital sponsor?

Dr. Ram Manohar Lohia Hospital is the lead sponsor of 4 current trials on ClinicalTrials.gov in our India register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Dr. Ram Manohar Lohia Hospital trials recruiting?

Yes. 1 of its 4 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.